<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00989820</url>
  </required_header>
  <id_info>
    <org_study_id>NL20963.091.08</org_study_id>
    <nct_id>NCT00989820</nct_id>
  </id_info>
  <brief_title>Efficacy of Hyperbaric Oxygen Therapy in the Treatment of Osteoradionecrosis</brief_title>
  <official_title>Efficacy of Adding Hyperbaric Oxygen Therapy to the Treatment of Late Radiation Damage of the Lower Jaw (Osteoradionecrosis).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether hyperbaric oxygen therapy is effective in
      the treatment of osteoradionecrosis (late damage after radiotherapy) of the jaw.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Late radiation damage to the lower jaw (osteoradionecrosis (ORN)) is often seen in patients
      treated with radiotherapy for a tumor in the head and neck region. Part of the lower jaw
      becomes non-vital and has to be treated. ORN proofs to be a condition difficult to treat and
      the treatment for this condition varies.

      In many countries hyperbaric oxygen therapy (HBOT) is added to the surgical treatment of ORN.
      Unfortunately there is no consensus whether the addition of hyperbaric oxygen therapy to the
      treatment of ORN is beneficial or not. This study has the aim to investigate the efficacy and
      cost-effectiveness of HBOT in the treatment of ORN
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment problems, patients refused to participate
  </why_stopped>
  <start_date type="Actual">October 2009</start_date>
  <completion_date type="Anticipated">May 1, 2018</completion_date>
  <primary_completion_date type="Actual">May 1, 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>absence of exposed bone, fistulae or ulceration.</measure>
    <time_frame>12 months after finishing therapy in the arm assigned to</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>one year after primairy therapy assigned to.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical and radiological assessment of the treatment response</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completion of the therapy in the arm for which patient has been randomized; if someone drops out of this study the reason will be scored.</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of pain medication</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of surgical intervention (sequestrectomy, marginal mandibula resection, segment resection)</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness</measure>
    <time_frame>one year after initial therapy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Osteoradionecrosis</condition>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This is the standard arm. Surgery without hyperbaric oxygen treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperbaric oxygen therapy with surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention arm. Hyperbaric oxygen therapy with surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hyperbaric oxygen</intervention_name>
    <description>30 session inhalation of 100% oxygen in a pressure chamber under 2.4 ATA for 90 minutes a day before surgery and 10 session hyperbaric oxygen therapy (as mentioned before) after surgery</description>
    <arm_group_label>Hyperbaric oxygen therapy with surgery</arm_group_label>
    <other_name>Linde Gas Therapeutics Benelux B.V.</other_name>
    <other_name>RVG 30355</other_name>
    <other_name>ATC code V03AN012</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Age ≥ 18 jr

          -  WHO performance status 0-2

          -  Last radiation treatment ≥ 6 month ago radiotherapy with curative intention and &gt; 55
             Gy. The affected part of the jaw must be in the target volume area of the radiotherapy
             field.

          -  Local recurrence must be ruled out

          -  Necrosis of the jaw with at least one of the following symptoms for over 3 month
             present:

               -  Bone exposition which measures at least 1 cm

               -  Evident bone lesions at radiologic evaluation (panorex) that fits the diagnosis
                  ORN.

               -  Non-healing extraction socket

        Exclusion Criteria:

          -  Former HBO treatment

          -  Contra indication for HBO treatment (pneumothorax)

          -  Bisphosphonate treatment in the medical history

          -  reirradiation in the medical history

          -  Osteosynthesis material in the affected area

          -  Distant metastasis

          -  Primary or recurrent tumor in the affected area

          -  Malignancies elsewhere
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francois Dieleman, MD DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thijs Merkx, MD DMD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans Kaanders, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Raboud University Medical Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NKI/AvL</name>
      <address>
        <city>Amsterdam</city>
        <zip>1066CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU University Medical centre</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <zip>2333ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht Universitary Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <zip>6229HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus University Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.nwhht.nl</url>
    <description>Dutch Co-operative Head and Neck Group</description>
  </link>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2009</study_first_submitted>
  <study_first_submitted_qc>October 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2009</study_first_posted>
  <last_update_submitted>May 29, 2017</last_update_submitted>
  <last_update_submitted_qc>May 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteoradionecrosis</keyword>
  <keyword>mandible</keyword>
  <keyword>radiotherapy</keyword>
  <keyword>hyperbaric oxygen therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoradionecrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

